Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables
- 11 February 2000
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 24 (3) , 193-199
- https://doi.org/10.1016/s0145-2126(99)00181-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- On the prognostic value of systemic methotrexate clearance in childhood acute lymphocytic leukemiaLeukemia Research, 1997
- Does pharmacokinetic variability influence the efficacy of high-dose methotrexate for the treatment of children with acute lymphoblastic leukemia: What can we learn from small studies?Leukemia Research, 1997
- Methotrexate pharmacokinetics and prognosis in osteosarcoma.Journal of Clinical Oncology, 1994
- Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.Journal of Clinical Oncology, 1994
- Serum Methotrexate (MTX) Concentrations and Prognosis in Patients with Osteosarcoma of the Extremities Treated with a Multidrug Neoadjuvant RegimenJournal of Chemotherapy, 1993
- Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.Journal of Clinical Oncology, 1991
- The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemiaBritish Journal of Cancer, 1991
- Systemic clearance of methotrexate in the prognosis of acute lymphoblastic leukemia in childrenCancer, 1987
- METHOTREXATE SYSTEMIC CLEARANCE INFLUENCES PROBABILITY OF RELAPSE IN CHILDREN WITH STANDARD-RISK ACUTE LYMPHOCYTIC LEUKAEMIAThe Lancet, 1984